Coram Clinical Trials is categorized under Home Health Care Services in Mount Prospect, IL .
Coram Clinical Trials was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Margaret Johnson, Vice President at the company’s branch by writing to 1471 East Business Center Drive # 500, Mount Prospect, Illinois IL 60056 or by phoning (847) 553-2727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Coram Clinical Trials |
| Contact Person: | Margaret Johnson, Vice President |
| Address: | 1471 East Business Center Drive # 500, Mount Prospect, Illinois 60056 |
| Phone Number: | (847) 553-2727 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6216100 |
| Share This Business: |
Coram Clinical Trials was started in 0 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Margaret Johnson, Vice President for inquiries that concern Coram Clinical Trials by calling the company number (847) 553-2727, as your correspondence is most welcome. Additionally, the physical location of the branch of Coram Clinical Trials can be found at the coordinates 42.07783,-87.9127 as well as the street address 1471 East Business Center Drive # 500 in Mount Prospect, Illinois 60056.
For its online presence, you may visit Coram Clinical Trials’s website at and engage with its social media outlets through on Twitter and on Facebook.